WaveSense develops, manufactures, and markets breakthrough analytical nanotechnologies for use in cellular and molecular assay markets. The company's patented and hierarchy technology is called Xenographic Retention Chromatography (XRC) - branded as EpiSep, which is a lateral flow separations platform that provides rapid, advanced detection and characterization of live cells, proteins, and/or genes. Researchers can then harvest the targets for interrogation purposes within their desired application.
Surface functionalization by methods of micro- and nanopatterning become more and more important in many applications of the life science sector. Zell-Kontakt GmbH develops and improves polymer and glass products in the areas analytics, applied pharmaceutical research and functional genomics.